Company profile · free preview
Sol-Gel Technologies Ltd.
SLGL · NASDAQ · Healthcare · Updated 11/13/2026
Five-year financials
| Fiscal year |
|---|
| Revenue |
| Net income |
| Diluted EPS |
| Operating cash flow |
| Free cash flow |
| Cash |
| Total debt |
Financials are being prepared.
Want the story behind these numbers? Ask Osiris anything about Sol-Gel Technologies Ltd.'s filings — free.
Create free accountSol-Gel Technologies Ltd. return on capital (fiscal 2025)
ROIC
—
Return on capital
—
Return on equity
-23.7%
Return on assets
-18.6%
Gross margin
—
Operating margin
-38.9%
Net debt / EBITDA
1.49x
Sol-Gel Technologies Ltd. insider buying and selling
Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-09-11 | Opaleye Management Inc. | Purchase | 1,493 | $65.94 |
| 2026-09-10 | Opaleye Management Inc. | Purchase | 1,631 | $66.80 |
| 2026-09-09 | Opaleye Management Inc. | Purchase | 3,097 | $68.70 |
| 2026-09-08 | Opaleye Management Inc. | Purchase | 471 | $69.37 |
| 2026-09-08 | Opaleye Management Inc. | Purchase | 3,390 | $68.74 |
| 2026-09-04 | Opaleye Management Inc. | Purchase | 2,100 | $68.98 |
| 2026-09-04 | Opaleye Management Inc. | Purchase | 918 | $69.52 |
| 2026-09-02 | Opaleye Management Inc. | Purchase | 900 | $68.95 |
SEC filings
No filings stored yet.
Ask anything about Sol-Gel Technologies Ltd.'s filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching freeCompare SLGL head-to-head
More Healthcare companies
Roche Holding AG RHHBYRevolution Medicines, Inc. RVMDRevvity, Inc. RVTYRhythm Pharmaceuticals, Inc. RYTMSenseonics Holdings, Inc. SENSSight Sciences, Inc. SGHTSiemens Healthineers AG SMMNYSOPHiA GENETICS S.A. SOPHNeuronetics, Inc. STIMStevanato Group S.p.A. STVNStryker Corporation SYKTScan Therapeutics, Inc. TCRX